fmc corp. - FMC
FMC
Close Chg Chg %
15.02 0.19 1.23%
Closed Market
15.21
+0.19 (1.23%)
Volume: 4.01M
Last Updated:
Jan 9, 2026, 3:59 PM EDT
Company Overview: fmc corp. - FMC
FMC Key Data
| Open $15.10 | Day Range 14.89 - 15.32 |
| 52 Week Range 12.18 - 57.00 | Market Cap $1.83B |
| Shares Outstanding 124.92M | Public Float 123.89M |
| Beta 0.66 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$4.25 |
| Yield 1,244.87% | Dividend $0.08 |
| EX-DIVIDEND DATE Dec 31, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 4.00M |
FMC Performance
| 1 Week | 4.67% | ||
| 1 Month | 7.91% | ||
| 3 Months | -48.38% | ||
| 1 Year | -69.73% | ||
| 5 Years | -87.60% |
FMC Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
22
Full Ratings ➔
About fmc corp. - FMC
FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.
FMC At a Glance
FMC Corp.
2929 Walnut Street
Philadelphia, Pennsylvania 19104
| Phone | 1-215-299-6000 | Revenue | 4.25B | |
| Industry | Chemicals: Agricultural | Net Income | 339.90M | |
| Sector | Process Industries | Employees | 5,700 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
FMC Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 17.928 |
| Price to Sales Ratio | 1.435 |
| Price to Book Ratio | 1.352 |
| Price to Cash Flow Ratio | 9.08 |
| Enterprise Value to EBITDA | 10.217 |
| Enterprise Value to Sales | 2.179 |
| Total Debt to Enterprise Value | 0.378 |
FMC Efficiency
| Revenue/Employee | 744,929.825 |
| Income Per Employee | 59,631.579 |
| Receivables Turnover | 1.341 |
| Total Asset Turnover | 0.36 |
FMC Liquidity
| Current Ratio | 1.642 |
| Quick Ratio | 1.244 |
| Cash Ratio | 0.118 |
FMC Profitability
| Gross Margin | 37.147 |
| Operating Margin | 15.419 |
| Pretax Margin | 5.947 |
| Net Margin | 8.005 |
| Return on Assets | 3.407 |
| Return on Equity | 9.029 |
| Return on Total Capital | 5.032 |
| Return on Invested Capital | 5.293 |
FMC Capital Structure
| Total Debt to Total Equity | 77.903 |
| Total Debt to Total Capital | 43.79 |
| Total Debt to Total Assets | 29.999 |
| Long-Term Debt to Equity | 69.838 |
| Long-Term Debt to Total Capital | 39.256 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Fmc Corp. - FMC
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 5.05B | 5.80B | 4.49B | 4.25B | |
Sales Growth
| +8.68% | +15.01% | -22.67% | -5.36% | |
Cost of Goods Sold (COGS) incl D&A
| 2.84B | 3.42B | 2.58B | 2.67B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 160.60M | 166.40M | 251.20M | 251.00M | |
Depreciation
| 97.90M | 105.80M | 186.90M | 185.50M | |
Amortization of Intangibles
| 62.70M | 60.60M | 64.30M | 65.50M | |
COGS Growth
| +10.37% | +20.09% | -24.51% | +3.50% | |
Gross Income
| 2.20B | 2.39B | 1.91B | 1.58B | |
Gross Income Growth
| +6.57% | +8.43% | -20.05% | -17.35% | |
Gross Profit Margin
| +43.63% | +41.14% | +42.53% | +37.15% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 1.02B | 1.10B | 1.07B | 922.60M | |
Research & Development
| 304.70M | 314.20M | 328.80M | 278.00M | |
Other SG&A
| 715.40M | 781.70M | 741.60M | 644.60M | |
SGA Growth
| +7.95% | +7.43% | -2.33% | -13.81% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 129.00M | 95.60M | 103.90M | 325.60M | |
EBIT after Unusual Expense
| 1.05B | 1.20B | 734.00M | 329.10M | |
Non Operating Income/Expense
| (31.40M) | (63.60M) | (199.00M) | 157.30M | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 126.90M | 147.80M | 234.80M | 233.90M | |
Interest Expense Growth
| -14.60% | +16.47% | +58.86% | -0.38% | |
Gross Interest Expense
| 130.30M | 153.40M | 244.10M | 243.50M | |
Interest Capitalized
| 3.40M | 5.60M | 9.30M | 9.60M | |
Pretax Income
| 893.80M | 983.90M | 300.20M | 252.50M | |
Pretax Income Growth
| +22.47% | +10.08% | -69.49% | -15.89% | |
Pretax Margin
| +17.72% | +16.96% | +6.69% | +5.95% | |
Income Tax
| 91.60M | 145.20M | (1.12B) | (150.90M) | |
Income Tax - Current - Domestic
| (14.70M) | 45.80M | 59.60M | 29.20M | |
Income Tax - Current - Foreign
| 96.60M | 152.10M | 113.90M | 160.20M | |
Income Tax - Deferred - Domestic
| 16.80M | (25.30M) | (80.80M) | (68.40M) | |
Income Tax - Deferred - Foreign
| (7.10M) | (27.40M) | (1.21B) | (271.90M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| (1.80M) | (1.70M) | (2.70M) | (1.20M) | |
Consolidated Net Income
| 800.40M | 837.00M | 1.42B | 402.20M | |
Minority Interest Expense
| (2.50M) | 5.00M | (500.00K) | 500.00K | |
Net Income
| 802.90M | 832.00M | 1.42B | 401.70M | |
Net Income Growth
| +38.81% | +3.62% | +70.35% | -71.66% | |
Net Margin Growth
| +15.91% | +14.34% | +31.59% | +9.46% | |
Extraordinaries & Discontinued Operations
| (68.20M) | (97.20M) | (98.50M) | (61.80M) | |
Discontinued Operations
| (68.20M) | (97.20M) | (98.50M) | (61.80M) | |
Net Income After Extraordinaries
| 734.70M | 734.80M | 1.32B | 339.90M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 734.70M | 734.80M | 1.32B | 339.90M | |
EPS (Basic)
| 5.7218 | 5.8329 | 10.5453 | 2.7191 | |
EPS (Basic) Growth
| +34.91% | +1.94% | +80.79% | -74.22% | |
Basic Shares Outstanding
| 128.40M | 125.97M | 125.06M | 125.00M | |
EPS (Diluted)
| 5.6889 | 5.7992 | 10.5056 | 2.7114 | |
EPS (Diluted) Growth
| +35.04% | +1.94% | +81.16% | -74.19% | |
Diluted Shares Outstanding
| 129.15M | 126.71M | 125.53M | 125.36M | |
EBITDA
| 1.34B | 1.46B | 1.09B | 905.70M | |
EBITDA Growth
| +4.93% | +8.62% | -25.27% | -16.84% | |
EBITDA Margin
| +26.59% | +25.12% | +24.27% | +21.33% |
Snapshot
| Average Recommendation | HOLD | Average Target Price | 18.794 | |
| Number of Ratings | 22 | Current Quarters Estimate | 0.111 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 2.552 | |
| Last Quarter’s Earnings | 1.195 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 2.987 | Next Fiscal Year Estimate | 3.066 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 13 | 13 | 19 | 14 |
| Mean Estimate | 0.11 | 0.55 | 2.55 | 3.07 |
| High Estimates | 0.32 | 0.77 | 3.92 | 4.78 |
| Low Estimate | -0.12 | 0.29 | 1.73 | 2.20 |
| Coefficient of Variance | 117.24 | 23.67 | 19.13 | 20.56 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 5 | 6 | 6 |
| OVERWEIGHT | 1 | 0 | 1 |
| HOLD | 14 | 14 | 15 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 2 | 2 | 1 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Fmc Corp. - FMC
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Fmc Corp. - FMC
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jan 6, 2026 | Eduardo E. Cordeiro Director | 31,546 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $13.98 per share | 441,013.08 |
| Jan 6, 2026 | Dirk A. Kempthorne Director | 56,460 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $13.98 per share | 789,310.80 |
| Jan 6, 2026 | K'Lynne Johnson Director | 34,923 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $13.87 per share | 484,382.01 |
| Aug 20, 2025 | Jacqueline D. Scanlan Executive VP & Chief HRO | 36,834 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $37.49 per share | 1,380,906.66 |
| Mar 7, 2025 | Carol Anthony Davidson Director | 6,000 | Open market or private purchase of non-derivative security Non-derivative transaction at $37.33 per share | 223,980.00 |
| Mar 6, 2025 | Ronaldo Pereira President, FMC | 48,837 | Open market or private purchase of non-derivative security Non-derivative transaction at $35.78 per share | 1,747,387.86 |
| Mar 6, 2025 | Ronaldo Pereira President, FMC | 8,164 | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acq or disposition of issuer shs Non-derivative transaction at $35.66 per share | 291,128.24 |
| Feb 27, 2025 | Michael F. Reilly EVP, General Counsel & Sec. | 33,831 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $38.25 per share | 1,294,035.75 |
| Feb 27, 2025 | Vsevolod Rostovtsev EVP & Chief Technology Officer | 11,523 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $38.25 per share | 440,754.75 |
| Feb 27, 2025 | Andrew David Sandifer EVP and CFO | 67,162 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $38.25 per share | 2,568,946.50 |
| Feb 27, 2025 | Nicholas L. Pfeiffer Corporate Controller | 15,716 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $38.25 per share | 601,137.00 |
| Feb 27, 2025 | Thaisa Hugenneyer EVP, Integrated Supply Chain | 13,899 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $38.25 per share | 531,636.75 |
| Feb 27, 2025 | Brian P. Angeli Ex. VP & Chief Marketing Off. | 10,145 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $38.25 per share | 388,046.25 |
| Feb 26, 2025 | Ronaldo Pereira President, FMC | 81,468 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Pierre R. Brondeau Chairman and CEO; Director | 259,674 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Thaisa Hugenneyer EVP, Integrated Supply Chain | 24,441 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Pierre R. Brondeau Chairman and CEO; Director | 244,439 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Brian P. Angeli Ex. VP & Chief Marketing Off. | 24,441 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Andrew David Sandifer EVP and CFO | 50,568 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Andrew David Sandifer EVP and CFO | 50,947 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $36.62 per share | 1,865,679.14 |